» Articles » PMID: 18046025

In Defense of Pharmacoepidemiology--embracing the Yin and Yang of Drug Research

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2007 Nov 30
PMID 18046025
Citations 58
Authors
Affiliations
Soon will be listed here.
Citing Articles

Rituximab Safety Profile: A Seven-Year Retrospective Analysis From Southern India.

Jayasree L, Palatty P, Govindraj L, Anand G, Dev G, Shabu B Cureus. 2024; 16(11):e74454.

PMID: 39726516 PMC: 11669735. DOI: 10.7759/cureus.74454.


A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review.

Ferreira-da-Silva R, Reis-Pardal J, Pinto M, Monteiro-Soares M, Sousa-Pinto B, Morato M Drug Saf. 2024; 47(12):1203-1224.

PMID: 39160354 PMC: 11554745. DOI: 10.1007/s40264-024-01470-0.


Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice.

Camejo N, Castillo C, Amarillo D, de Los Santos H, Samurio G, Silva-Marquez A World J Oncol. 2024; 15(3):454-462.

PMID: 38751695 PMC: 11092421. DOI: 10.14740/wjon1829.


Association between long-term use of calcium channel blockers (CCB) and the risk of breast cancer: a retrospective longitudinal observational study protocol.

Ho C, Thi Ha N, Youens D, Abhayaratna W, Bulsara M, Hughes J BMJ Open. 2024; 14(3):e080982.

PMID: 38458796 PMC: 10928765. DOI: 10.1136/bmjopen-2023-080982.


The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers.

Pratt N, Camacho X, Vajdic C, Degenhardt L, Laba T, Hillen J Int J Popul Data Sci. 2022; 6(3):1726.

PMID: 35784493 PMC: 9208358. DOI: 10.23889/ijpds.v6i1.1726.